[1]
“CLINICAL UTILITY OF CA125, HE4 AND RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) FOR EARLY DETECTION OF OVARIAN CARCINOMA”, Int. Res. J. Pharm., vol. 8, no. 6, pp. 1–7, Nov. 2024, Accessed: May 26, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/810